Novavax Announces Submission Of COVID-19 Vaccine To WHO For Emergency Use Listing

Novavax, Inc. (NVAX), with its partner, Serum Institute of India, announced a regulatory submission to the World Health Organization for emergency use listing of Novavax' protein-based COVID-19 vaccine candidate. The grant of emergency use listing by the WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility.

"Today's submission is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world," said Stanley Erck, President and CEO, Novavax.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
HSBC Holdings Plc shares were gaining In London trading as well as in pre-market activity on the NYSE after the Asia-focused lender backed its positive outlook after reporting significantly higher third-quarter profit. Further, the company announced share buyback of $2 billion, which will be commenced shortly. Walmart is recalling certain Aromatherapy Room Spray due to the possible presence of a rare and dangerous bacteria that is suspected to be behind two deaths in the United States, the U.S. Consumer Product Safety Commission said. The recall involves about 3,900 bottles of Better Homes and Gardens-branded Essential Oil Infused Aromatherapy Room Spray with Gemstones in six different scents. Royal Caribbean Group's ultra-luxury brand Silversea Cruises is set to launch the world's first hybrid-powered cruise ship in the summer of 2023. This will also be the first ship with large-scale fuel cell technology to enable emission-free port operations. The fuel cells will provide 100% of power while at port.
Follow RTT